CIO 2023-1 Four-year Overall Survival from the HIMALAYA Study of Tremelimumab + Durvalumab in Unresectable Hepatocellular Carcinoma

Stephen Chan, MD – Dr, State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Sir Yue-Kong Pao Center for Cancer, The Chinese University of Hong Kong, Hong Kong SAR, China; Robin Kate Kelley, MD – Dr, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; George Lau, MD, FRCP – Dr, Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong SAR, China; Masatoshi Kudo, MD, PhD – Prof, Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan; Wattana Sukeepaisarnjaroen, MD – Dr, Department of Medicine, Songklanagarind Hospital, Khon Kaen University, Khon Kaen, Thailand; Enrico De Toni, MD, PhD – Prof, Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; Junji Furuse, MD, PhD – Prof, Kanagawa Cancer Center, Yokohama, Japan; Yoo Koo Kang, MD, PhD – Prof, Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Peter Galle, MD, PhD – Prof, Department of Internal Medicine I, University Medical Center, Mainz, Germany; Lorenza Rimassa, MD – Dr, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy and Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Alexandra Heurgué, MD – Dr, Department of Hepato-Gastroenterology, Robert-Debré Hospital, Reims, France; Vincent Tam, MD – Dr, Tom Baker Cancer Centre, Department of Oncology, University of Calgary, Calgary, AB, Canada; Tu Van Dao, MD, PhD – Prof, Cancer Research and Clinical Trials Center, Department of Optimal Therapy, National Cancer Hospital, Hanoi, Vietnam; Satheesh Chiradoni Thungappa, MD – Dr, Health Care Global Enterprises Ltd, Bangalore, India; Valeriy Breder, MD, PhD – Prof, N. N. Blokhin Russian Cancer Research Center, Chemotherapy Unit, Moscow, Russia; Yuriy Ostapenko, MD – Dr, Department of Minimally Invasive and Endoscopic Surgery, Interventional Radiology, National Cancer Institute, Kyiv, Ukraine; Maria Reig, MD, PhD – Prof, Barcelona Clinic Liver Cancer (BCLC), Liver Unit, Hospital Clinic de Barcelona, IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain; Mallory Makowsky, PharmD – Dr, Oncology R&D, Late-Stage Development, AstraZeneca, Gaithersburg, MD, USA; Charu Gupta, MSc – Dr, Oncology Biometrics, Late Oncology Statistics, AstraZeneca, Wilmington, DE, USA; Alejandra Negro, PhD – Dr, Oncology R&D, Late-Stage Development, AstraZeneca, Gaithersburg, MD, USA; Bruno Sangro, MD, PhD – Prof, Liver Unit and HPB Oncology Area, Clínica Universidad de Navarra and CIBEREHD, Pamplona, Spain